| 1 |
Maron BJ. Clinical course and management of hypertrophic cardiomyopathy [J]. N Engl J Med, 2018, 379(7): 655-668.
|
| 2 |
Semsarian C, Ingles J, Maron MS, et al. New perspectives on the prevalence of hypertrophic cardiomyopathy [J]. J Am Coll Cardiol, 2015, 65(12): 1249-1254.
|
| 3 |
Maron BJ, Shirani J, Poliac LC, et al. Sudden death in young competitive athletes. Clinical, demographic, and pathological profiles [J]. JAMA, 1996, 276(3): 199-204.
|
| 4 |
Elliott PM, Anastasakis A, Borger MA, et al. 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC) [J]. Eur Heart J, 2014, 35(39): 2733-2779.
|
| 5 |
中华医学会心血管病学分会, 中华医学会心血管病学分会中国成人肥厚型心肌病诊断与治疗指南编写组, 中华心血管病杂志编辑委员会. 中国成人肥厚型心肌病诊断与治疗指南 [J]. 中华心血管病杂志, 2017, 45(12): 1015-1032.
|
| 6 |
Maron BJ, Spirito P, Roman MJ, et al. Prevalence of hypertrophic cardiomyopathy in a population-based sample of American Indians aged 51 to 77 years (the Strong Heart Study) [J]. Am J Cardiol, 2004, 93(12): 1510-1514.
|
| 7 |
Maron BJ, Gardin JM, Flack JM, et al. Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults [J]. Circulation, 1995, 92(4): 785-789.
|
| 8 |
Zou Y, Song L, Wang Z, et al. Prevalence of idiopathic hypertrophic cardiomyopathy in China: a population-based echocardiographic analysis of 8080 adults [J]. Am J Med, 2004, 116(1): 14-18.
|
| 9 |
Spirito P, Bellone P, Harris KM, et al. Magnitude of left ventricular hypertrophy and risk of sudden death in hypertrophic cardiomyopathy [J]. N Engl J Med, 2000, 342(24): 1778-1785.
|
| 10 |
Maron MS, Hauser TH, Dubrow E, et al. Right ventricular involvement in hypertrophic cardiomyopathy [J]. Am J Cardiol, 2007, 100(8): 1293-1298.
|
| 11 |
Guo X, Fan C, Wang H, et al. The prevalence and long-term outcomes of extreme right versus extreme left ventricular hypertrophic cardiomyopathy [J]. Cardiology, 2016, 133(1): 35-43.
|
| 12 |
Maron BJ, McKenna WJ, Danielson GK, et al. American College of Cardiology/European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines [J]. Eur Heart J, 2003, 24(21): 1965-1991.
|
| 13 |
Kim DH, Handschumacher MD, Levine RA, et al. In vivo measurement of mitral leaflet surface area and subvalvular geometry in patients with asymmetrical septal hypertrophy: insights into the mechanism of outflow tract obstruction [J]. Circulation, 2010, 122(13): 1298-1307.
|
| 14 |
Maron MS, Olivotto I, Betocchi S, et al. Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy [J]. N Engl J Med, 2003, 348(4): 295-303.
|
| 15 |
Maron MS, Olivotto I, Zenovich AG, et al. Hypertrophic cardiomyopathy is predominantly a disease of left ventricular outflow tract obstruction [J]. Circulation, 2006, 114(21): 2232-2239.
|
| 16 |
Pantazis A, Vischer AS, Perez-Tome MC, et al. Diagnosis and management of hypertrophic cardiomyopathy [J]. Echo Res Pract, 2015, 2(1): R45-R53.
|
| 17 |
乔树宾, 袁建松. 肥厚型心肌病的治疗 [J]. 国际心血管病杂志, 2011, 38(1): 9-13.
|
| 18 |
Dimitrow PP, Bober M, Michałowska J, et al. Left ventricular outflow tract gradient provoked by upright position or exercise in treated patients with hypertrophic cardiomyopathy without obstruction at rest [J]. Echocardiography, 2009, 26(5): 513-520.
|
| 19 |
Morise AP. Exercise testing in nonatherosclerotic heart disease: hypertrophic cardiomyopathy, valvular heart disease, and arrhythmias [J]. Circulation, 2011, 123(2): 216-225.
|
| 20 |
Gao XJ, Kang LM, Zhang J, et al. Mid-ventricular obstructive hypertrophic cardiomyopathy with apical aneurysm and sustained ventricular tachycardia: a case report and literature review [J]. Chin Med J (Engl), 2011, 124(11): 1754-1757.
|
| 21 |
安硕研, 樊朝美, 赵世华, 等. 左心室中部肥厚型梗阻性心肌病的临床特点及预后[J]. 中国循环杂志, 2015, 30(11): 1053-1057.
|
| 22 |
Hensley N, Dietrich J, Nyhan D, et al. Hypertrophic cardiomyopathy: a review [J]. Anesth Analg, 2015, 120(3): 554-569.
|
| 23 |
Geske JB, Ommen SR, Gersh BJ. Hypertrophic cardiomyopathy: clinical update [J]. JACC Heart Fail, 2018, 6(5): 364-375.
|
| 24 |
Weissler-Snir A, Crean A, Rakowski H. The role of imaging in the diagnosis and management of hypertrophic cardiomyopathy [J]. Expert Rev Cardiovasc Ther, 2016, 14(1): 51-74.
|
| 25 |
Sherrid MV, Balaram S, Kim B, et al. The mitral valve in obstructive hypertrophic cardiomyopathy: a test in context [J]. J Am Coll Cardiol, 2016, 67(15): 1846-1858.
|
| 26 |
Patil PV, Wiegers SE. Echocardiography for hypertrophic cardiomyopathy [J]. Prog Cardiovasc Dis, 2014, 57(1): 91-99.
|
| 27 |
陈绍良, 段宝祥, 何晓红, 等. 梗阻性肥厚型心肌病经皮化学消蚀术后长期随访研究 [J]. 中国介入心脏病学杂志, 2003, 11(1): 21-24.
|
| 28 |
Elliott PM, Kaski JC, Prasad K, et al. Chest pain during daily life in patients with hypertrophic cardiomyopathy: an ambulatory electrocardiographic study [J]. Eur Heart J, 1996, 17(7): 1056-1064.
|
| 29 |
樊朝美. 肥厚型心肌病诊断与治疗必读 [M]. 北京: 科技出版社, 2016.
|
| 30 |
乔树宾, 宋云虎. 肥厚型心肌病-基础与临床 [M]. 北京: 人民卫生出版社, 2012.
|
| 31 |
Marian AJ. Pathogenesis of diverse clinical and pathological phenotypes in hypertrophic cardiomyopathy [J]. Lancet, 2000, 355(9197): 58-60.
|
| 32 |
Maron BJ. Contemporary insights and strategies for risk stratification and prevention of sudden death in hypertrophic cardiomyopathy [J]. Circulation, 2010, 121(3): 445-456.
|
| 33 |
Smiseth OA, Torp H, Opdahl A, et al. Myocardial strain imaging: how useful is it in clinical decision making? [J] Eur Heart J, 2015, 37(15): 1196-1207.
|
| 34 |
Kalam K, Otahal P, Marwick TH. Prognostic implications of global LV dysfunctions: a systematic review and meta-analysis of global longitudinal strain and ejection fraction [J]. Heart, 2014, 100(21): 1673-1680.
|
| 35 |
Haland TF, Almaas VM, Hasselberg NE, et al. Strain echocardiography is related to fibrosis and ventricular arrhythmias in hypertrophic cardiomyopathy [J]. Eur Heart J Cardiovasc Imaging, 2016, 17(6): 613-621.
|
| 36 |
Kitaoka H, Doi Y, Casey SA, et al. Comparison of prevalence of apical hypertrophic cardiomyopathy in Japan and the United States [J]. Am J Cardiol, 2003, 92(10): 1183-1186.
|
| 37 |
闫丽荣, 樊朝美. 心尖肥厚型心肌病的研究进展 [J]. 中华心血管病学杂志, 2011, 39(10): 970-972.
|
| 38 |
Efthimiadis GK, Pagourelias ED, Parcharidou D, et al. Clinical characteristics and natural history of hypertrophic cardiomyopathy with midventricular obstruction [J]. Circ J, 2013, 77(9): 2366-2374.
|
| 39 |
蔡迟, 樊朝美. 左心室中部肥厚型梗阻性心肌病的研究进展 [J]. 中华心血管病学杂志, 2012, 40 (12): 1064-1067.
|
| 40 |
Harris KM, Spirito P, Maron MS, et al. Prevalence, clinical profile, and significance of left ventricular remodeling in the end-stage phase of hypertrophic cardiomyopathy [J]. Circulation, 2006, 114(3): 216-225.
|
| 41 |
Xiao Y, Yang KQ, Jiang Y, et al. Recent progress in end-stage hypertrophic cardiomyopathy [J]. Am J Med Sci, 2015, 349(5): 448-453.
|
| 42 |
Nagueh SF, Kopelen HA, Lim DS, et al. Tissue Doppler imaging consistently detects myocardial contraction and relaxation abnormalities, irrespective of cardiac hypertrophy in a transgenic rabbit model of human hypertrophic cardiomyopathy [J]. Circulation, 2000, 102(12): 1346-1350.
|
| 43 |
Marian AJ, Wu Y, Lim DS, et al. A transgenic rabbit model for human hypertrophic cardiomyopathy [J]. J Clin Invest, 1999, 104(12): 1683-1692.
|
| 44 |
Nagueh SF, Bachinski LL, Meyer D, et al. Tissue doppler imaging consistently detects myocardial abnormalities in patients with hypertrophic cardiomyopathy and provides a novel means for an early diagnosis before and independently of hypertrophy [J]. Circulation, 2001,104(2): 128-130.
|
| 45 |
Kitaoka H, Kubo T, Okawa M, et al. Utility of tissue doppler imaging to predict exercise capacity in hypertrophic cardiomyopathy: comparison with B-type natriuretic peptide [J]. J Cardiol, 2009, 53(3): 361-367.
|
| 46 |
Pouleur AC, le Polain de Waroux JB, Pasquet A, et al. Assessment of left ventricular mass and volumes by three-dimensional echocardiography in patients with or without wall motion abnormalities: comparison against cine magnetic resonance imaging [J]. Heart, 2008, 94(8): 1050-1057.
|
| 47 |
马春燕, 任卫东, 唐力, 等. 实时三维超声心动图评价左室心肌肥厚患者的心肌收缩同步性 [J]. 中国医学影像技术, 2008, 24(3): 390-392.
|
| 48 |
Abozguia K, Nallur-Shivu G, Phan TT, et al. Left ventricular strain and untwist in hypertrophic cardiomyopathy: relation to exercise capacity [J]. Am Heart J, 2010, 159(5): 825-832.
|
| 49 |
Garceau P, Carasso S, Woo A, et al. Evaluation of left ventricular relaxation and filling pressures in obstructive hypertrophic cardiomyopathy: comparison between invasive hemodynamics and two-dimensional speckle tracking [J]. Echocardiography, 2012, 29(8): 934-942.
|
| 50 |
雷常慧, 刘丽文, 纳丽莎, 等. 三维斑点追踪技术评价肥厚型心肌病患者左心室整体应变的研究 [J]. 中华超声影像学杂志, 2014, 23(5): 377-382.
|
| 51 |
刘雪云, 雷常慧, 刘丽文, 等. 三维斑点追踪技术评价肥厚型心肌病患者左心室收缩不同步性 [J]. 中华超声影像学杂志, 2014, 23(10): 835-841.
|
| 52 |
许丹, 刘丽文, 王玉, 等. 三维斑点追踪技术对家族性肥厚型心肌病突变携带者的早期识别 [J]. 中华超声影像学杂志, 2016, 25(10): 834-839.
|
| 53 |
张娟, 王静, 朱晓丽, 等. 三维斑点追踪技术联合常规超声心动图评价肥厚型心肌病肌小节突变携带者左室功能的早期改变 [J]. 中华超声影像学杂志, 2020, 29(02): 104-109.
|
| 54 |
Urbano Moral JA, Arias Godinez JA, Maron MS, et al. Left ventricular twist mechanics in hypertrophic cardiomyopathy assessed by three-dimensional speckle tracking echocardiography [J]. Am J Cardiol, 2011, 108(12): 1788-1795.
|
| 55 |
Baccouche H, Maunz M, Beck T, et al. Differentiating cardiac amyloidosis and hypertrophic cardiomyopathy by use of three-dimensional speckle tracking echocardiography [J]. Echocardiography, 2012, 29(6): 668-677.
|
| 56 |
Badran HM, Faheem N, Ibrahim WA, et al. Systolic function reserve using two-dimensional strain imaging in hypertrophic cardiomyopathy: comparison with essential hypertension [J]. J Am Soc Echocardiogr, 2013, 26(12): 1397-1406.
|
| 57 |
Soullier C, Obert P, Doucende G, et al. Exercise response in hypertrophic cardiomyopathy: blunted left ventricular deformational and twisting reserve with altered systolic-diastolic coupling [J]. Circ Cardiovasc Imaging, 2012, 5(3): 324-332.
|
| 58 |
D′Andrea A, Limongelli G, Baldini L, et al. Exercise speckle tracking strain imaging demonstrates impaired right ventricular contractile reserve in hypertrophic cardiomyopathy [J]. Int J Cardiol, 2017, 227: 209-216.
|
| 59 |
中华医学会超声医学分会超声心动图学组. 中国心血管超声造影检查专家共识 [J]. 中华超声影像学杂志, 2016, 25(4): 277-293.
|
| 60 |
Igata S, Kraushaar M, Strachan M, et al. Systematic assessment of the impact of ultrasound-enhancing agents upon measurements of cardiac size and function of by echocardiography [J]. J Am Soc Echocardiogr, 2020; 33(3): 313-321.
|
| 61 |
王纯, 邓又斌, 朱英, 等. 超声造影评价肥厚型心肌病患者伴心肌致密化不全 [J/CD]. 中华医学超声杂志(电子版), 2011, 8(10): 2111-2117.
|
| 62 |
Watanabe N, Akasaka T, Yamaura Y, et al. Intramyocardial coronary flow characteristics in patients with hypertrophic cardiomyopathy: non-invasive assessment by transthoracic doppler echocardiography [J]. Heart, 2003, 89(6): 657-658.
|
| 63 |
王婷, 邓又斌, 朱英, 等. 心肌超声造影评价肥厚型心肌病患者局部心肌收缩功能与灌注的关系 [J/CD]. 中华医学超声杂志(电子版), 2011, 8(10): 2104-2110.
|
| 64 |
Himbert D, Brochet E, Ducrocq G, et al. Contrast echocardiography guidance for alcohol septal ablation of hypertrophic obstructive cardiomyopathy [J]. Eur Heart J, 2010, 31(9): 1148.
|
| 65 |
Moya Mur JL, Salido Tahoces L, Mestre Barcelo JL, et al. Three-dimensional contrast echocardiography-guided alcohol septal ablation in hypertrophic obstructive cardiomyopathy [J]. Eur Heart J Cardiovasc Imaging, 2014, 15(2): 226.
|
| 66 |
栾姝蓉, 李治安, 何怡华, 等. 心肌声学造影超声心动图在肥厚性梗阻型心肌病化学消融术中的作用 [J]. 中华超声影像学杂志, 2002, 11(12): 709-712.
|
| 67 |
Labombarda F, Pellissier A, Saloux É. Fibrosis suggested by 3D contrast-enhanced echocardiography in hypertrophic cardiomyopathy [J]. Arch Cardiovasc Dis, 2011, 104(12): 680-681.
|